Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The erythromycin breath test for the prediction of drug clearance.
Rivory LP, Slaviero KA, Hoskins JM, Clarke SJ. Rivory LP, et al. Clin Pharmacokinet. 2001;40(3):151-8. doi: 10.2165/00003088-200140030-00001. Clin Pharmacokinet. 2001. PMID: 11327195 Review.
Factors affecting cytochrome P-450 3A activity in cancer patients.
Baker SD, van Schaik RH, Rivory LP, Ten Tije AJ, Dinh K, Graveland WJ, Schenk PW, Charles KA, Clarke SJ, Carducci MA, McGuire WP, Dawkins F, Gelderblom H, Verweij J, Sparreboom A. Baker SD, et al. Among authors: rivory lp. Clin Cancer Res. 2004 Dec 15;10(24):8341-50. doi: 10.1158/1078-0432.CCR-04-1371. Clin Cancer Res. 2004. PMID: 15623611
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.
Wong M, Balleine RL, Blair EY, McLachlan AJ, Ackland SP, Garg MB, Evans S, Farlow D, Collins M, Rivory LP, Hoskins JM, Mann GJ, Clarke CL, Gurney H. Wong M, et al. Among authors: rivory lp. J Clin Oncol. 2006 Jun 1;24(16):2448-55. doi: 10.1200/JCO.2005.02.1295. Epub 2006 May 1. J Clin Oncol. 2006. PMID: 16651648
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy.
Slaviero KA, Clarke SJ, Rivory LP. Slaviero KA, et al. Among authors: rivory lp. Lancet Oncol. 2003 Apr;4(4):224-32. doi: 10.1016/s1470-2045(03)01034-9. Lancet Oncol. 2003. PMID: 12681266 Review.
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.
Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ. Le Couteur DG, et al. Among authors: rivory lp. Clin Pharmacokinet. 2005;44(2):187-200. doi: 10.2165/00003088-200544020-00004. Clin Pharmacokinet. 2005. PMID: 15656697 Review.
Predicting the toxicity of weekly docetaxel in advanced cancer.
Charles KA, Rivory LP, Stockler MR, Beale P, Beith J, Boyer M, Clarke SJ. Charles KA, et al. Among authors: rivory lp. Clin Pharmacokinet. 2006;45(6):611-22. doi: 10.2165/00003088-200645060-00004. Clin Pharmacokinet. 2006. PMID: 16719542 Clinical Trial.
Population pharmacokinetics of weekly docetaxel in patients with advanced cancer.
Slaviero KA, Clarke SJ, McLachlan AJ, Blair EY, Rivory LP. Slaviero KA, et al. Among authors: rivory lp. Br J Clin Pharmacol. 2004 Jan;57(1):44-53. doi: 10.1046/j.1365-2125.2003.01956.x. Br J Clin Pharmacol. 2004. PMID: 14678339 Free PMC article. Clinical Trial.
Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.
Charles KA, Rivory LP, Brown SL, Liddle C, Clarke SJ, Robertson GR. Charles KA, et al. Among authors: rivory lp. Clin Cancer Res. 2006 Dec 15;12(24):7492-7. doi: 10.1158/1078-0432.CCR-06-0023. Clin Cancer Res. 2006. PMID: 17189422 Free article.
Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, Clarke CL, Balleine RL, Gurney H. Wong M, et al. Among authors: rivory lp. Clin Pharmacol Ther. 2005 Jan;77(1):33-42. doi: 10.1016/j.clpt.2004.09.002. Clin Pharmacol Ther. 2005. PMID: 15637529
Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
Blair EY, Rivory LP, Clarke SJ, McLachlan AJ. Blair EY, et al. Among authors: rivory lp. Br J Clin Pharmacol. 2004 Apr;57(4):416-26. doi: 10.1111/j.1365-2125.2003.02050.x. Br J Clin Pharmacol. 2004. PMID: 15025739 Free PMC article. Clinical Trial.
73 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback